Publications by Arne Westheim
127 publications found
Original articles
β-Blocker Doses and Heart Rate in Patients with Heart Failure: Results from the National Norwegian Heart Failure Registry
Biomed Hub, 5 (1), 9-18
DOI 10.1159/000505474, PubMed 32775329
ESC guidelines adherence is associated with improved survival in patients from the Norwegian Heart Failure Registry
Eur Heart J Cardiovasc Pharmacother, 1 (1), 31-6
DOI 10.1093/ehjcvp/pvu010, PubMed 27533962
Improved quality of life in Norwegian heart failure patients after follow-up in outpatient heart failure clinics: results from the Norwegian Heart Failure Registry
Eur J Heart Fail, 12 (11), 1247-52
DOI 10.1093/eurjhf/hfq156, PubMed 20847014
No effect of group-based aerobic interval training on N-terminal pro- B-type natriuretic peptide levels in patients with chronic heart failure
Scand Cardiovasc J, 44 (4), 223-9
DOI 10.3109/14017431.2010.496869, PubMed 20636229
Characteristics, implementation of evidence-based management and outcome in patients with chronic heart failure: results from the Norwegian heart failure registry
Eur J Cardiovasc Nurs, 10 (1), 44-9
DOI 10.1016/j.ejcnurse.2010.04.001, PubMed 20452825
Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea
Am J Cardiol, 104 (7), 966-71
DOI 10.1016/j.amjcard.2009.05.039, PubMed 19766765
Effects of group-based high-intensity aerobic interval training in patients with chronic heart failure
Am J Cardiol, 102 (10), 1361-5
DOI 10.1016/j.amjcard.2008.07.016, PubMed 18993156
Long-term effects of a group-based high-intensity aerobic interval-training program in patients with chronic heart failure
Am J Cardiol, 102 (9), 1220-4
DOI 10.1016/j.amjcard.2008.06.046, PubMed 18940296
Lipid lowering treatment patterns and goal attainment in Nordic patients with hyperlipidemia
Scand Cardiovasc J, 42 (4), 279-87
DOI 10.1080/14017430802073073, PubMed 18609053
Pain and quality of life in hospitalized patients with heart failure
J Pain Symptom Manage, 36 (5), 497-504
DOI 10.1016/j.jpainsymman.2007.11.014, PubMed 18619766
Group-based aerobic interval training in patients with chronic heart failure: Norwegian Ullevaal Model
Phys Ther, 88 (4), 523-35
DOI 10.2522/ptj.20060374, PubMed 18258768
How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study
Am Heart J, 151 (5), 999-1005
DOI 10.1016/j.ahj.2005.10.011, PubMed 16644321
N-terminal pro-B-type natriuretic peptide in risk stratification after acute myocardial infarction in patients on long-term beta-adrenergic receptor blocker therapy
Cardiology, 106 (2), 102-8
DOI 10.1159/000092743, PubMed 16636540
[How are patients with acute coronary syndromes treated in Norwegian hospitals?]
Tidsskr Nor Laegeforen, 125 (21), 2925-8
PubMed 16276372
[Primary angioplasty in acute ST elevation myocardial infarction in the elderly]
Tidsskr Nor Laegeforen, 125 (21), 2922-4
PubMed 16276371
B-type natriuretic peptide levels in patients in the emergency department with possible heart failure and previous stable angina pectoris and/or healed myocardial infarction
Am J Cardiol, 96 (10), 1370-3
DOI 10.1016/j.amjcard.2005.07.040, PubMed 16275180
Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study
J Am Coll Cardiol, 46 (5), 838-44
DOI 10.1016/j.jacc.2005.05.057, PubMed 16139134
Predictors of elevated B-type natriuretic peptide concentrations in dyspneic patients without heart failure: an analysis from the breathing not properly multinational study
Ann Emerg Med, 45 (6), 573-80
DOI 10.1016/j.annemergmed.2005.01.027, PubMed 15940086
Insulin sensitivity in women with coronary heart disease during hormone replacement therapy
J Womens Health (Larchmt), 14 (2), 137-45
DOI 10.1089/jwh.2005.14.137, PubMed 15775731
A comparison of the two beta-blockers carvedilol and atenolol on left ventricular ejection fraction and clinical endpoints after myocardial infarction. a single-centre, randomized study of 232 patients
Cardiology, 103 (3), 148-55
DOI 10.1159/000084584, PubMed 15785019
[Prevention of myocardial infarction and stroke with statins]
Tidsskr Nor Laegeforen, 124 (13-14), 1821
PubMed 15229678
Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study
Am Heart J, 147 (6), 1078-84
DOI 10.1016/j.ahj.2004.01.013, PubMed 15199359
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)
Circulation, 109 (13), 1594-602
DOI 10.1161/01.CIR.0000124490.27666.B2, PubMed 15023878
Diagnostic value of B-Type natriuretic peptide and chest radiographic findings in patients with acute dyspnea
Am J Med, 116 (6), 363-8
DOI 10.1016/j.amjmed.2003.10.028, PubMed 15006584
[Statin therapy for hypertensive patients]
Tidsskr Nor Laegeforen, 124 (2), 165-6
PubMed 14743227
Diagnostic value of a rapid test for B-type natriuretic peptide in patients presenting with acute dyspnoe: effect of age and gender
Eur J Heart Fail, 6 (1), 55-62
DOI 10.1016/j.ejheart.2003.10.006, PubMed 15012919
Plasma leptin in postmenopausal women with coronary artery disease: effect of transdermal 17beta-estradiol and intermittent medroxyprogesterone acetate
Climacteric, 6 (3), 204-10
DOI 10.1080/713605412, PubMed 14567768
[B-type natriuretic peptide and clinical judgement in the diagnosis of heart failure in patients presenting with acute dyspnoea]
Tidsskr Nor Laegeforen, 123 (15), 2045-8
PubMed 12934128
Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study
J Am Coll Cardiol, 41 (11), 2010-7
DOI 10.1016/s0735-1097(03)00405-4, PubMed 12798574
Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department
Acad Emerg Med, 10 (3), 198-204
DOI 10.1111/j.1553-2712.2003.tb01990.x, PubMed 12615582
B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study
Am J Kidney Dis, 41 (3), 571-9
DOI 10.1053/ajkd.2003.50118, PubMed 12612980
Smoking and relation to other risk factors in postmenopausal women with coronary artery disease, with particular reference to whole blood viscosity and beta-cell function
J Intern Med, 253 (2), 232-9
DOI 10.1046/j.1365-2796.2003.01110.x, PubMed 12542565
Implementation of guidelines to screen relatives of patients with premature coronary heart disease in a hospital setting
Am J Cardiol, 90 (11), 1211-4
DOI 10.1016/s0002-9149(02)02836-9, PubMed 12450600
B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study
Circulation, 106 (4), 416-22
DOI 10.1161/01.cir.0000025242.79963.4c, PubMed 12135939
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure
N Engl J Med, 347 (3), 161-7
DOI 10.1056/NEJMoa020233, PubMed 12124404
Lower plasma noradrenaline and blood viscosity on carvedilol vs atenolol in men with recent myocardial infarction
Blood Press, 11 (6), 377-84
DOI 10.1080/080370502321095357, PubMed 12523682
Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine
Cardiology, 98 (1-2), 6-12
DOI 10.1159/000064667, PubMed 12373040
Blood pressure levels in treated hypertensive patients in general practice in Norway
Blood Press, 10 (1), 37-42
DOI 10.1080/080370501750183372, PubMed 11332332
How well are patients with atherosclerotic disease treated? Secondary prevention in primary care
Scand J Prim Health Care, 18 (4), 232-6
DOI 10.1080/028134300448805, PubMed 11205092
[Prescription patterns of antihypertensive agents in general practice in 1995]
Tidsskr Nor Laegeforen, 120 (10), 1136-40
PubMed 10863341
The EWA (estrogen in women with atherosclerosis) study: a randomized study of the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipoproteins
J Intern Med, 247 (4), 433-41
DOI 10.1046/j.1365-2796.2000.00675.x, PubMed 10792556
Increased plasma concentrations of TGF-beta1 after hormone replacement therapy
J Intern Med, 247 (2), 279-85
DOI 10.1046/j.1365-2796.2000.00648.x, PubMed 10692092
Adverse drug reactions in current antihypertensive therapy: a general practice survey of 2586 patients in Norway
Blood Press, 8 (2), 94-101
DOI 10.1080/080370599438266, PubMed 10451036
[How well are patients with atherosclerosis treated in general practice? Risk factors and intervention surveyed in 1996-97 as compared to two previous years]
Tidsskr Nor Laegeforen, 118 (15), 2308-13
PubMed 9691796
Arterial and venous plasma catecholamines during submaximal steady-state exercise
Clin Physiol, 18 (2), 109-15
DOI 10.1046/j.1365-2281.1998.00083.x, PubMed 9568349
Evidence of excess hereditary predisposition in women with angiographically documented coronary artery disease
Cardiology, 90 (4), 249-52
DOI 10.1159/000006853, PubMed 10085484
[Risk factors and intervention in cardiovascular diseases in general practice]
Tidsskr Nor Laegeforen, 116 (21), 2562-5
PubMed 8928126
[Treatment of hypertension in 1994. Comments on the 1993 guidelines of the Norwegian Society of General Practitioners concerning the treatment program for hypertension]
Tidsskr Nor Laegeforen, 114 (17), 1990-2
PubMed 8079331
[Chronic heart failure. A management program. Proposal for diagnosis and treatment]
Tidsskr Nor Laegeforen, 114 (12), 1424-7
PubMed 8079230
Left ventricular mass and cardiovascular reactivity in young men
Hypertension, 23 (1 Suppl), I168-71
DOI 10.1161/01.hyp.23.1_suppl.i168, PubMed 8282352
Cardiovascular reactivity, coronary risk factors, and sympathetic activity in young men
Hypertension, 22 (6), 891-9
DOI 10.1161/01.hyp.22.6.891, PubMed 8244522
Regional differences of atrial natriuretic factors in humans
Clin Physiol, 13 (2), 153-60
DOI 10.1111/j.1475-097x.1993.tb00376.x, PubMed 8453869
Sex differences in essential hypertension
J Intern Med, 233 (1), 13-9
DOI 10.1111/j.1365-2796.1993.tb00641.x, PubMed 8429281
Haemodynamic and neurohumoral effects of cold pressor test in severe heart failure
Clin Physiol, 12 (1), 95-106
DOI 10.1111/j.1475-097x.1992.tb00296.x, PubMed 1541087
[Ambulatory non-invasive 24-hour blood pressure measurement--do we need it?]
Tidsskr Nor Laegeforen, 111 (18), 2280-2
PubMed 1896989
Faster and more reliable absorption of adrenaline by aerosol inhalation than by subcutaneous injection
Br J Clin Pharmacol, 31 (6), 677-81
DOI 10.1111/j.1365-2125.1991.tb05592.x, PubMed 1867961
[The effect of doxazosin on blood pressure, lipids, fibrinogen and plasminogen activator inhibitor. A comparative study among smokers and non-smokers with essential hypertension]
Tidsskr Nor Laegeforen, 111 (9), 1102-5
PubMed 1827216
Awareness of high blood pressure increases arterial plasma catecholamines, platelet noradrenaline and adrenergic responses to mental stress
J Hypertens, 9 (2), 159-66
DOI 10.1097/00004872-199102000-00010, PubMed 1849532
Renal haemodynamic and sympathetic responses to head-up tilt in essential hypertension
Scand J Clin Lab Invest, 50 (8), 815-22
DOI 10.3109/00365519009104947, PubMed 2084819
Selective alpha 1 inhibition with doxazosin in hypertensive smokers and non-smokers: haemodynamic and metabolic effects
J Hypertens Suppl, 8 (5), S41-6
PubMed 1981076
Late sequelae of lung contusion
Injury, 20 (5), 253-6
DOI 10.1016/0020-1383(89)90160-5, PubMed 2613303
Effect of dopamine and dopamine-antagonist infusion on blood platelet count, size and release reaction in hypertensive and normotensive subjects
Scand J Clin Lab Invest, 49 (4), 307-15
DOI 10.3109/00365518909089102, PubMed 2525805
Hyper-responsiveness to low-dose epinephrine infusion in mild essential hypertension
J Hypertens Suppl, 6 (4), S581-3
DOI 10.1097/00004872-198812040-00182, PubMed 3241257
Decreased serum phosphate in essential hypertension. Related to increased sympathetic tone
Am J Hypertens, 1 (4 Pt 1), 403-9
DOI 10.1093/ajh/1.4.403, PubMed 3214562
Changes in coronary haemodynamics and myocardial metabolism at rest and during exercise after a cardiotonic drug (prenalterol) in patients with coronary artery disease
Clin Physiol, 8 (5), 463-74
DOI 10.1111/j.1475-097x.1988.tb00212.x, PubMed 3191661
Sodium depletion increases platelet and plasma catecholamines in hypertensive men
Hypertension, 11 (5), 477-82
DOI 10.1161/01.hyp.11.5.477, PubMed 3366481
Increased platelet and vascular smooth muscle reactivity to low-dose adrenaline infusion in mild essential hypertension
J Hypertens, 6 (3), 219-25
DOI 10.1097/00004872-198803000-00006, PubMed 2966193
Increased platelet size and release reaction in essential hypertension
J Hypertens, 5 (4), 401-6
PubMed 2959720
Endocrine and haemodynamic responses to graded dopamine infusion in essential hypertension
Scand J Clin Lab Invest, 47 (4), 371-7
PubMed 3602915
PA Patch--a new patch testing device. Preliminary report
J Am Acad Dermatol, 16 (5 Pt 1), 961-3
DOI 10.1016/s0190-9622(87)70121-2, PubMed 3584580
[Sodium restriction in hypertension. Sympathetic tonus, renin and vasopressin]
Tidsskr Nor Laegeforen, 107 (10-11), 954-7
PubMed 3299859
Haemodynamics during repeated exercise tests with special reference to the 'warm-up' phenomenon in patients with angina pectoris
Clin Physiol, 7 (2), 83-94
DOI 10.1111/j.1475-097x.1987.tb00150.x, PubMed 3568584
Severe sodium restriction alone and with potassium supplementation does not alter blood lipoproteins in essential hypertension
Eur J Clin Invest, 17 (2), 182-6
DOI 10.1111/j.1365-2362.1987.tb02398.x, PubMed 3108006
Decreased central dopaminergic activity in essential hypertension
J Hypertens, 5 (2), 191-7
DOI 10.1097/00004872-198704000-00010, PubMed 3611768
A comparative study on the effect of atenolol and labetalol on exercise capacity and lipid serum levels in essential hypertension
Nephron, 47 Suppl 1, 135-7
DOI 10.1159/000184572, PubMed 3320787
Increased platelet release reaction in 50-year-old men with essential hypertension: correlation with atherogenic cholesterol fractions
Am Heart J, 113 (1), 151-5
DOI 10.1016/0002-8703(87)90023-8, PubMed 2948378
Aging and urinary vasopressin excretion in healthy men
Scand J Urol Nephrol, 21 (3), 235-9
DOI 10.3109/00365598709180328, PubMed 3433025
DECREASED NORADRENERGIC SYMPATHETIC TONE DURING CONTROLLED LONG-TERM LOW SODIUM TREATMENT OF MILD ESSENTIAL-HYPERTENSION
J. Hypertens., 4 6, S200-S202
BLOOD-PLATELET SIZE, PLATELET-RELEASE REACTION AND RESPONSE TO INFUSED ADRENALINE ARE INCREASED IN MILD ESSENTIAL-HYPERTENSION
J. Hypertens., 4 6, S234-S236
Increased plasma noradrenaline during severe sodium restriction does not stimulate platelet release in essential hypertension
Thromb Haemost, 56 (2), 120-3
PubMed 2949387
Plasma adrenaline and noradrenaline during orthostasis in man: the importance of arterial sampling
Scand J Clin Lab Invest, 46 (5), 397-401
DOI 10.3109/00365518609083689, PubMed 3749784
Increased plasma vasopressin in low renin essential hypertension
Hypertension, 8 (6), 506-13
DOI 10.1161/01.hyp.8.6.506, PubMed 2872161
BLOOD-PLATELET RELEASE CORRELATES WITH SERUM-LIPIDS IN 50-YEAR-OLD MEN WITH ESSENTIAL-HYPERTENSION
Acta Med. Scand. (714), 125-128
Hemodynamic effects at rest and during exercise in long-term treatment with prazosin in chronic congestive heart failure
Acta Med Scand, 219 (5), 449-53
DOI 10.1111/j.0954-6820.1986.tb03338.x, PubMed 3526819
EFFECT OF EXERCISE TRAINING IN PATIENTS WITH ESSENTIAL-HYPERTENSION
Acta Med. Scand. (714), 99-103
Central dopaminergic control of prolactin in essential hypertension
Acta Med Scand Suppl, 714, 113-7
DOI 10.1111/j.0954-6820.1986.tb08978.x, PubMed 3472433
PLATELET VOLUME - PLATELET-RELEASE REACTION AND PLATELET RESPONSE TO INFUSED ADRENALINE ARE INCREASED IN ESSENTIAL-HYPERTENSION
Acta Med. Scand. (714), 129-132
Blood platelet release correlates with serum lipids in 50 year old men with essential hypertension
Acta Med Scand Suppl, 714, 125-8
DOI 10.1111/j.0954-6820.1986.tb08980.x, PubMed 2953173
The effect of sodium depletion and potassium supplementation on vasopressin, renin and catecholamines in hypertensive men
Acta Med Scand, 220 (3), 195-203
DOI 10.1111/j.0954-6820.1986.tb02751.x, PubMed 3535395
CENTRAL DOPAMINERGIC CONTROL OF PROLACTIN IN ESSENTIAL-HYPERTENSION
Acta Med. Scand. (714), 113-117
Serum phosphate and sympathetic tone in mild essential hypertension
Acta Med Scand Suppl, 714, 119-23
DOI 10.1111/j.0954-6820.1986.tb08979.x, PubMed 3472434
Platelet volume, platelet release reaction and platelet response to infused adrenaline are increased in essential hypertension
Acta Med Scand Suppl, 714, 129-32
DOI 10.1111/j.0954-6820.1986.tb08981.x, PubMed 2953174
Hormonal responses to treatment of high blood pressure with low-salt diet alone and combined with added potassium
Acta Med Scand Suppl, 714, 93-7
DOI 10.1111/j.0954-6820.1986.tb08975.x, PubMed 3554904
SERUM PHOSPHATE AND SYMPATHETIC TONE IN MILD ESSENTIAL-HYPERTENSION
Acta Med. Scand. (714), 119-123
Effect of exercise training in patients with essential hypertension
Acta Med Scand Suppl, 714, 99-103
DOI 10.1111/j.0954-6820.1986.tb08976.x, PubMed 3472452
HORMONAL RESPONSES TO TREATMENT OF HIGH BLOOD-PRESSURE WITH LOW-SALT DIET ALONE AND COMBINED WITH ADDED POTASSIUM
Acta Med. Scand. (714), 93-97
Acute hemodynamic effects of propranolol, glycerylnitrate, and exercise in coronary patients with left ventricular dysfunction
Int J Cardiol, 9 (4), 465-75
DOI 10.1016/0167-5273(85)90242-6, PubMed 3935584
Effect of exercise training in patients with essential hypertension
J Hypertens Suppl, 3 (3), S479-81
PubMed 2856772
[Occurrence of angina pectoris. A study among 40-49-year-old men in Oslo (the Oslo study) evaluated by a questionnaire and clinical diagnosis]
Tidsskr Nor Laegeforen, 105 (26), 1779-82
PubMed 4060123
Venous thrombosis following diagnostic transvenous catheterization by percutaneous catheter insertion: an evaluation of desmopressin as a thromboprophylactic agent
Thromb Haemost, 52 (2), 121-3
PubMed 6395435
Arteriovenous difference of plasma vasopressin in normal man and effect of posture
Acta Physiol Scand, 122 (1), 49-53
DOI 10.1111/j.1748-1716.1984.tb07480.x, PubMed 6239521
Renal contribution to plasma catecholamines--effect of age
Scand J Clin Lab Invest, 42 (5), 461-6
PubMed 7156858
Acute epiglottitis in children--(an evaluation of the role of tracheotomy)
J Laryngol Otol, 93 (10), 995-1001
DOI 10.1017/s0022215100088010, PubMed 512471
[Continuous 24-hour ECG monitoring. 1 year of experience with the Holter-Avionics portable ECG monitor]
Tidsskr Nor Laegeforen, 96 (28), 1469-71
PubMed 982371
[Papaverine and liver damage. Investigation of liver function in 25 patients treated with papaverine intra-arterially]
Tidsskr Nor Laegeforen, 92 (30), 2020-2
PubMed 4634644
[Purulent meningitis. Cerebral apoplexy as a differential diagnosis]
Nord Med, 85 (8), 238-40
PubMed 5552736
[Wolff-Parkinson-White syndrome. Electrocardiographic reason in false diagnosis of heart disease]
Nord Med, 84 (31), 973-8
PubMed 5453092
Review articles
[Congestive heart failure--etiology and diagnostic procedures]
Tidsskr Nor Laegeforen, 127 (2), 171-3
PubMed 17237863
[Treatment of congestive heart failure]
Tidsskr Nor Laegeforen, 127 (2), 174-7
PubMed 17237864
[Chronic heart failure--suggestion to a management program]
Tidsskr Nor Laegeforen, 119 (23), 3427-31
PubMed 10553340
[An overview of hypertension studies with calcium antagonists]
Tidsskr Nor Laegeforen, 119 (13), 1878-82
PubMed 10382332
[Treatment of heart failure with beta-blockaders]
Tidsskr Nor Laegeforen, 117 (4), 526-8
PubMed 9148453
[Chronic left heart ventricle failure and inotropic stimulation]
Tidsskr Nor Laegeforen, 115 (3), 360-4
PubMed 7855836
[Physical activity and the metabolic syndrome]
Tidsskr Nor Laegeforen, 113 (6), 723-4
PubMed 8465338
Physical activity and the metabolic cardiovascular syndrome
J Cardiovasc Pharmacol, 20 Suppl 8, S49-53
PubMed 1283770
Other articles
Could adverse events offset the benefit of intensive blood pressure lowering treatment in the Systolic Blood Pressure Intervention Trial?
J Hypertens, 37 (5), 902-904
DOI 10.1097/HJH.0000000000002018, PubMed 30920495
Warning on diuretic use
J Am Coll Cardiol, 55 (23), 2609-10; author reply 2610
DOI 10.1016/j.jacc.2010.02.039, PubMed 20513605
DISSOCIATION OF BLOOD-PRESSURE LEVEL AND REACTIVITY - REPLY
Hypertension, 23 (5), 676-677
[Can antihypertensive treatment prevent myocardial infarction?]
Tidsskr Nor Laegeforen, 113 (25), 3162
PubMed 7903829
Doxazosin in combination with atenolol in essential hypertension: a double-blind placebo-controlled multicentre trial
Eur J Clin Pharmacol, 39 (3), 299-300
DOI 10.1007/BF00315116, PubMed 2147909
Bopindolol versus metoprolol in hypertension
Eur J Clin Pharmacol, 31 (3), 379-80
DOI 10.1007/BF00981143, PubMed 2878814
Does arterial rather than venous plasma beta-thromboglobulin better reflect in vivo platelet release reaction?
Thromb Haemost, 54 (2), 547
PubMed 2417355
Books
Hjertesvikt: årsaker, diagnostikk og behandling
AstraZeneca, Oslo (8. utg.,), 42 s.
BIBSYS 092986617, ISBN 82-994596-1-3
Hjertesvikt: årsaker, diagnostikk og behandling
AstraZeneca AS, Skårer (6. utg.), 42 s.
BIBSYS 07176173x, ISBN 82-994596-1-3
Hjertesvikt: årsaker, diagnostikk og behandling
AstraZeneca AS, Skårer (5. utg.), 42 s.
BIBSYS 041251016, ISBN 82-994596-1-3
Book chapters
Smoking and relation to other risk factors in postmenopausal women with coronary artery disease, with particular reference to whole blood viscosity and beta-cell function
In Journal of internal medicine, Blackwell Scientific Publ., Oxford, 253(2003)2, s.232-9
BIBSYS 041722221
Theses
Importance and limitations of stress tests in hemodynamicstudies
Department of Medicine, Division of Cardiology, Ullevål Hospital, University of Oslo, Oslo, 1 b. (flere pag.)
BIBSYS 920629946, ISBN 82-992591-1-8